Search Results | MSF Science Portal

Journal Article

|

Research

Apolisi I, Cox HS, Tyeku N, Daniels J, Mathee S, et al.

2023-02-21 • Open Forum Infectious Diseases

BACKGROUND
Children and adolescents with household exposure to multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB) are at high risk of developing TB disease. Tuberculosis pre...

Journal Article

|

Research

Murphy RA, Douglas-Jones B, Mucinya G, Sunpath H, Govender T

2021-09-01 • International Journal of Tuberculosis and Lung Disease

The wider availability of dolutegravir (DTG) containing HIV therapy for patients living with multidrug-resistant TB (MDR-TB) presents several advantages. DTG-based antiretroviral therapy...

Journal Article

|

Letter

Mohr-Holland E, Daniels J, Douglas-Jones B, Mema N, Scott V, et al.

2021-05-01 • International Journal of Tuberculosis and Lung Disease

Journal Article

|

Letter

Douglas-Jones B, Mohr-Holland E, Mema N, Mathee S, Mathews G, et al.

2021-07-01 • International Journal of Tuberculosis and Lung Disease

Journal Article

|

Commentary

Mohr-Holland E, Douglas-Jones B, Apolisi I, Ngambu N, Mathee S, et al.

2021-03-01 • Lancet Child and Adolescent Health

Science Portal

Tuberculosis diagnosis and preventive monotherapy among children and adolescents exposed to rifampicin-resistant tuberculosis in the household

Expanding the use of dolutegravir-based antiretroviral therapy in multidrug-resistant TB

A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients

A home-based care programme for rifampicin-resistant TB

Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic